N. Katori, N. Aoyagi, and T. Terao. Estimation of agitation intensity in the GI tract in human and dog based on in vitro/in vivo correlation. Pharm. Res.
12: 245–251 (1995).
J. C. Bain, S. B. Tan, D. Ganderton, and M. C. Solomon. A discrepancy between pharmacopoeial dissolution tests and bioavailability. Pharm. Tech. Int.
2: 36–40 (1990).
S. Aoki, H. Ando, K. Tatsuishi, K. Uesugi, and H. Ozawa. Determination of the mechanical impact force in the in vitro dissolution test and evaluation of the correlation between in vivo and in vitro release. Int. J. Pharm.
95: 67–75 (1993).
C. G. Wilson, N. Washington, J. L. Greaves, F. Kamali, J. A. Rees, A. K. Sempik, and J. F. Lampard. Bimodal release of ibuprofen in a sustained-release formulation: A scintigraphic and pharmacokinetic open study in healthy volunteers under different condition of food intake. Int. J. Pharm.
50: 155–161 (1989).
C. G. Wilson, N. Washington, J. L. Greaves, C. Washington, I. R. Wilding, T. Hoadley, and E. E. Sims. Predictive modeling of the behavior of a controlled release buflomedil HCl formulation using scintigraphic and pharmacokinetic data. Int. J. Pharm.
72: 79–86 (1991).
B. Abrahamsson, M. Alpsten, M. Hugosson, U. E. Jonsson, M. Sundgren, A. Svenheden, and J. Tolli. Absorption, gastrointestinal transit and tablet erosion of felodipine extended-release tablets. Pharm. Res.
10: 709–714 (1993).
K. Wingstrand, B. Abrahamsson, and B. Edgar. Bioavailability from felodipine extended-release tablets with different dissolution properties. Int. J. Pharm.
60: 151–156 (1990).
K. Sako, T. Mizumoto, T. Kajiyama, and T. Omura. In vitro and in vivo release behavior of erodable and non-erodable sustain release tablets of acetaminophen. Proceedings of the 6th Conference of the Academy of Pharmaceutical Society. and Technology, Japan. p. 25–27 (1990).
A. Adithan and J. Thangam. A comparative study of saliva and serum paracetamol levels using simple spectrophotometric method. Br. J. Clin. Pharmacol.
14: 107–109 (1982).
D. Verotta. An Inequality-constrained least squares deconvolution method. J. Pharmacokinet. Biopharm.
17: 269–289 (1986).
K. Yamaoka, T. Tanigawara, T. Nakagawa, and T. Uno. A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharmacobio-Dyn.
4: 879–885 (1981).
H. Ogata, T. Shibazaki, T. Inoue, and A. Ejima. Dissolution system for chloramphenicol tablet bioavailability. J. Pharm. Sci.
68: 712–715 (1979).
H. Ogata, N. Aoyagi, N. Kaniwa, and A. Ejima. Effect of food on the bioavailability of metronidazole from sugar coated tablets having different dissolution rates in subjects with low gastric acidity. Int. J. Clin. Pharmacol. Ther. Toxicol.
24: 279–282 (1986).
S. K. El-Arini, G. K. Shiu, and J. P. Skelly. Theophylline controlled release preparations and fatty food: An in vitro study using rotating dialysis cell method. Pharm. Res.
7: 1134–1140 (1990).
T. Mizumoto, K. Sako and M. Fukui. In vitro/in vivo correlation of single unit CR dosage forms. Abstract of 111th Conference of Pharmaceutical Society of Japan. No.4: p.105 (1991)
S.S. Davis, J.G. Hardy and J.W. Fara. Transit of pharmaceutical dosage forms through the small intestine. Gut.
27: 885–892 (1986).
N. Aoyagi, N. Kaniwa, Y. Takeda and M. Uchiyama. The purpose of dissolution test in Japanese Pharmacopoeia and its application principles. J P Forum. 3: 46 (1994).
Z. Hussain and M. Friedman. Release and absorption characteristics of novel theophylline sustained-release formulations-In vitro-in vivo correlation. Pharm. Res.
7: 1167–1171 (1990).
H. Ogata, N. Aoyagi, N. Kaniwa, T. Shibazaki, A. Ejima, N. Takasugi, E. Mafune, T. Hayashi, and K. Suwa. Bioavailability of nalidixic acid from uncoated tablets in humans. Part I: Correlation with the dissolution rates of the tablets. Int. J. Clin. Pharmacol.Ther.Toxicol.
22: 175–183 (1984).
R. Dietrich, R. Brausse, G. Benedikt and V.W. Steinijans. Feasibility of in vitro/in vivo correlation in the case of a new sustained-release theophylline pellet formulation. Arzneim-Forsch.
38: 1229–1237 (1988).
N. Kaniwa, H. Ogata, N. Aoyagi, T. Shibazaki, A. Ejima, Y. Watanabe, K. Motohashi, K. Sasahara, E. Nakajima, T. Morioka, and T. Nitanai. The bioavailability of flufenamic acid and its dissolution from capsules. Int. J. Clin. Pharmacol. Ther. Toxicol.
21: 56–63 (1983).
T. Kimura, K. Sudo, Y. Kanezaki, K. Miki, Y. Takeichi, Y. Kurosaki and T. Nakayama: Drug absorption from large intestine: Physicochemical factors governing drug absorption. Biol. Pharm. Bull.
17: 327–333 (1994).
H. Nakajima, K. Sako, T. Sawada, A. Okada and M. Fukui. Continuously absorbable oral delivery systems using acetaminophen. Abstract of 114th Conference of Pharmaceutical Society of Japan. No.4: p.37 (1994).